MEDICINOVA INC (MNOV)
US58468P2065 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 51.00M | 18.50M | 71.40M | 60.00M | 63.80M | |||
| Marketable Securities | 0.00 | 40.00M | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 174.94K | 500.00K | 600.00K | 700.00K | 500.00K | |||
| Total Current Assets | 51.17M | 59.00M | 72.00M | 60.70M | 64.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 621.21K | 700.00K | 900.00K | 100.00K | 400.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | 9.60M | 9.60M | 9.60M | 9.60M | 9.60M | |||
| Intangibles | 4.80M | 4.80M | 4.80M | 4.80M | 4.80M | |||
| Other Non-Current Assets | 74.15K | 100.00K | 100.00K | 200.00K | 100.00K | |||
| Total Non-Current Assets | 15.10M | 15.20M | 15.40M | 14.70M | 14.90M | |||
| TOTAL ASSETS | 66.27M | 74.20M | 87.40M | 75.40M | 79.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 2.28M | 2.80M | 2.40M | 1.60M | 1.80M | |||
| Accounts Payable | 1.00M | 400.00K | 400.00K | 600.00K | 500.00K | |||
| Total Current Liabilities | 3.28M | 3.20M | 2.80M | 2.20M | 2.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 201.79K | 200.00K | 200.00K | 200.00K | 200.00K | |||
| Other Non-Current Liabilities | 410.66K | 500.00K | 700.00K | 1.70M | 1.90M | |||
| Total Non-Current Liabilities | 612.45K | 700.00K | 900.00K | 1.90M | 2.10M | |||
| TOTAL LIABILITIES | 3.89M | 3.90M | 3.70M | 4.10M | 4.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -415.70M | -407.10M | -393.10M | -382.90M | -369.10M | |||
| Additional Paid In Capital | 478.15M | 477.40M | 476.80M | 454.30M | 444.00M | |||
| Common Shares | 49.05K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -118.09K | -100.00K | -100.00K | -100.00K | -100.00K | |||
| Shares Outstanding | 49.05M | 49.00M | 49.00M | 45.00M | 43.90M | |||
| Tangible Book Value per Share | 0.98 | 1.14 | 1.41 | 1.26 | 1.38 | |||
| Total Shareholders' Equity | 62.38M | 70.20M | 83.70M | 71.30M | 74.90M | |||
| TOTAL LIABILITIES AND EQUITY | 66.27M | 74.20M | 87.40M | 75.40M | 79.20M | |||
| Statistics | ||||||||
| Current Ratio | 15.61 | 18.44 | 25.71 | 27.59 | 29.23 | |||
| Return On Assets (ROA) | -12.93% | -18.96% | -11.59% | -18.37% | -16.34% | |||
| Return On Equity (ROE) | -13.74% | -20.04% | -12.10% | -19.42% | -17.28% | |||
All data in USD